Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-1.16%Buyback Yield
VS
Market
Sector
Industry
History
$ 5.19Close
$ 0.84 - $ 5.94 52-Week Range
Ticker Information
Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGALECTIN THERAPEUTICS INC - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GALT - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | -1.16% | $ 240.87M | $ 2.79M |
| 3/31/2025 | -1.47% | $ 83.54M | $ 1.23M |
| 12/31/2024 | -1.59% | $ 77.08M | $ 1.23M |
| 9/30/2024 | -0.22% | $ 172.6M | $ 376K |
| 6/30/2024 | -7.43% | $ 140.13M | $ 10.41M |
| 3/31/2024 | -5.28% | $ 190.17M | $ 10.03M |
| 12/31/2023 | -6.78% | $ 147.95M | $ 10.03M |
| 9/30/2023 | -8.32% | $ 120.6M | $ 10.03M |
| 6/30/2023 | 0% | $ 88.78M | $ 0 |
| 3/31/2023 | 0% | $ 97.71M | $ 0 |
Key Performance Insights, Last 5 Years
- GALECTIN THERAPEUTICS INC's latest trailing twelve months (TTM) Buyback Yield stands at -0.81%.
- Over the past 5 years, GALECTIN THERAPEUTICS INC's average Buyback Yield has been -2.85%.
- The median Buyback Yield for GALECTIN THERAPEUTICS INC during this period was -1.31%
- GALECTIN THERAPEUTICS INC reached its highest Buyback Yield over the past 5 years at 0%.
- The lowest Buyback Yield recorded by GALECTIN THERAPEUTICS INC in the same timeframe -9.11%
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for GALECTIN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 1.17M ]) / Market Cap [ $ 143.83M ]
(=) Buyback Yield [ -0.81% ] GALT - Buyback Yield, Last 5 years
-9.11%
Minimum
Mar 31, 2022
0%
Maximum
Sep 30, 2022
-2.85%
Average
-1.31%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.46% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |